便秘的甜美面:糖尿病中结肠运动功能障碍
Michelantonio De Fano1, Sara Baluganti2, Marcello Manco1
1Endocrine and Metabolic Sciences Section, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Nutrients
|October 16, 2025
概括
慢性便秘在糖尿病中很常见,GLP-1RA药物可以使其恶化. 管理包括生活方式的改变,药,以及对严重病例的新疗法.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性便秘是糖尿病患者常见的胃肠道问题,比一般人群更常见.
- 本综述系统地检查了DM中便秘,这是一个经常被低估的临床疾病.
研究的目的:
- 为糖尿病患者提供慢性便秘的全面概述.
- 探索病变发生,诊断-治疗框架,以及GLP-1受体激活剂 (GLP-1RA) 在DM患者便秘中的作用.
主要方法:
- 在2025年5月30日之前进行了叙事文献综述.
- 审查的重点是研究DM中便秘的致病性,与GLP-1RA治疗的相关性以及诊断治疗策略的研究.
主要成果:
- 在DM中便秘的确切机制尚未完全理解,但可能是多因素的,涉及肠道结构和功能变化,通常与高血糖有关.
- 葡萄糖类-1受体激活剂 (GLP-1RA),对于2型糖尿病管理至关重要,被确定为导致便秘的因素.
- 诊断主要依赖于临床评估,因为经过验证的结肠过境评估是侵入性的和专门的.
- 治疗包括饮食调整,体力活动,药,以及潜在的新药或严重病例的机械方法.
结论:
- 医疗保健专业人员必须承认慢性便秘是DM患者日益增长的人群中的一个重大临床问题.
- 使用可引起便秘的GLP-1RA等药物需要在管理DM患者时仔细考虑.
相关概念视频
Gastrointestinal Motility Disorders
1.1K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.1K
Assessment of the Rectum and Anus
1.1K
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
1.1K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.2K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.2K
Drugs for Treatment of Constipation-Predominant IBS
712
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
712
Drugs Affecting GI Tract Motility: Other Laxatives
1.0K
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.0K
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
524
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
524


